Cargando…
The nocebo effect challenges the non-medical infliximab switch in practice
BACKGROUND: In clinical practice, non-medical switching of biological medication may provoke nocebo effects due to unexplained deterioration of therapeutic benefits. Indication extrapolation, idiosyncratic reactions, and interchangeability remain challenged in clinical practice after biosimilar appr...
Autores principales: | Boone, N. W., Liu, L., Romberg-Camps, M. J., Duijsens, L., Houwen, C., van der Kuy, P. H. M., Janknegt, R., Peeters, R., Landewé, R. B. M., Winkens, B., van Bodegraven, A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893662/ https://www.ncbi.nlm.nih.gov/pubmed/29368188 http://dx.doi.org/10.1007/s00228-018-2418-4 |
Ejemplares similares
-
The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
por: Derijks, Hieronymus J., et al.
Publicado: (2008) -
Defining antimicrobial prescribing quality indicators: what is a new prescription?
por: Boesten, Jos, et al.
Publicado: (2010) -
Switching from a traditional undergraduate programme in (clinical) pharmacology and therapeutics to a problem-based learning programme
por: Brinkman, David J., et al.
Publicado: (2020) -
Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
por: van Orten-Luiten, A. C. B., et al.
Publicado: (2016) -
The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions
por: Reumerman, M., et al.
Publicado: (2021)